Quest Diagnostics is trading higher today, showing resilience despite a broader decline in the healthcare sector following a surprising drop in the Conference Board Consumer Confidence Index.
The stock is outperforming several of its industry peers, such as Labcorp Holdings, which is seeing only modest gains, and Henry Schein, which is trading slightly lower. This positive momentum occurs as investors continue to evaluate the stability of consumer spending on healthcare services, a segment often viewed as a